- Home
- BTU vs WGS Comparison
BTU vs WGS Comparison
Compare BTU & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTU
- WGS
- Stock Information
- Founded
- BTU 2016
- WGS 2017
- Country
- BTU United States
- WGS United States
- Employees
- BTU N/A
- WGS N/A
- Industry
- BTU Coal Mining
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- BTU Energy
- WGS Technology
- Exchange
- BTU Nasdaq
- WGS Nasdaq
- Market Cap
- BTU 2.0B
- WGS 2.4B
- IPO Year
- BTU N/A
- WGS N/A
- Fundamental
- Price
- BTU $17.56
- WGS $126.36
- Analyst Decision
- BTU Buy
- WGS Strong Buy
- Analyst Count
- BTU 6
- WGS 7
- Target Price
- BTU $22.33
- WGS $99.29
- AVG Volume (30 Days)
- BTU 5.6M
- WGS 999.1K
- Earning Date
- BTU 07-31-2025
- WGS 07-29-2025
- Dividend Yield
- BTU 1.71%
- WGS N/A
- EPS Growth
- BTU N/A
- WGS N/A
- EPS
- BTU 1.10
- WGS 0.05
- Revenue
- BTU $4,038,200,000.00
- WGS $362,321,000.00
- Revenue This Year
- BTU N/A
- WGS $22.16
- Revenue Next Year
- BTU $18.30
- WGS $19.63
- P/E Ratio
- BTU $15.67
- WGS $2,581.68
- Revenue Growth
- BTU N/A
- WGS 48.70
- 52 Week Low
- BTU $9.61
- WGS $28.86
- 52 Week High
- BTU $29.94
- WGS $127.36
- Technical
- Relative Strength Index (RSI)
- BTU 59.05
- WGS 80.63
- Support Level
- BTU $16.96
- WGS $102.97
- Resistance Level
- BTU $18.84
- WGS $108.92
- Average True Range (ATR)
- BTU 0.91
- WGS 7.24
- MACD
- BTU 0.05
- WGS 2.38
- Stochastic Oscillator
- BTU 72.11
- WGS 97.55
About BTU Peabody Energy Corporation
Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.